Back to Dashboard
APLS · Unknown

Apellis Pharmaceuticals Inc

USA Unknown Filing: 2026-03-31
38/100
Smart-money confidence1 of 3 sources positive
Weak — few signals

No standout activity across the feeds we track.

Hedge funds
51
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Who's behind the signal
Every informed buyer we can see on APLS, across all three feeds.
Hedge funds · 9
Soros Fund Management (Soros) New position
Point72 (Steve Cohen) Increased +600%
Tudor Investment (Paul Tudor Jones) Increased +202%
Millennium Management (Englander) Increased +138%
Gotham Asset Mgmt (Greenblatt) Decreased −53%
Bridgewater Associates (Dalio) Decreased −76%
+3 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Not a model pick — but on our radar. APELLIS PHARMACEUTICALS INC isn't in the top-10 model right now, but 9 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
9
Investors
1
New positions
3
Increasing
5
Decreasing
0
Unchanged
Price History
Loading price data...
Return: High: Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Soros Fund Management (Soros)
Trust weight: 1.5×
New position
% of portfolio
0.8%
Position change
NEW
0.8% of Soros Fund Management's portfolio
Point72 (Steve Cohen)
Trust weight: 1.1×
Increased +600%
% of portfolio
0.3%
Position change
+600%
0.3% of Point72's portfolio
Tudor Investment (Paul Tudor Jones)
Trust weight: 1.2×
Increased +202%
% of portfolio
0.1%
Position change
+202%
0.1% of Tudor Investment's portfolio
Millennium Management (Englander)
Trust weight: 1.0×
Increased +138%
% of portfolio
0.1%
Position change
+138%
0.1% of Millennium Management's portfolio
Gotham Asset Mgmt (Greenblatt)
Trust weight: 1.1×
Decreased −53%
% of portfolio
0.0%
Position change
−53%
0.0% of Gotham Asset Mgmt's portfolio
Bridgewater Associates (Dalio)
Trust weight: 1.3×
Decreased −76%
% of portfolio
0.0%
Position change
−76%
0.0% of Bridgewater Associates's portfolio
D.E. Shaw & Co
Trust weight: 1.0×
Decreased −58%
% of portfolio
0.0%
Position change
−58%
0.0% of D.E. Shaw & Co's portfolio
AQR Capital Management
Trust weight: 1.0×
Decreased −81%
% of portfolio
0.0%
Position change
−81%
0.0% of AQR Capital Management's portfolio
Citadel Advisors
Trust weight: 1.0×
Decreased −94%
% of portfolio
0.0%
Position change
−94%
0.0% of Citadel Advisors's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to APELLIS PHARMACEUTICALS INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell APELLIS PHARMACEUTICALS INC or any security.

订阅每周更新

我们每周会把巴菲特、达利欧、阿克曼以及另外 47 位传奇投资人正在买入的股票发送给你 — 免费，直接来自他们的 SEC 申报文件。
永久免费 · 无垃圾邮件 · 随时退订
© 2026 Bogen Capital  ·  Not financial advice  ·  Data delayed up to 135 days Methodology  ·  Contact  ·  API